Monoclonal antibody EBM11 (anti-CD68) discriminates between dendritic cells and macrophages after short-term culture

M G Betjes1, M C Haks, C W Tuk

  • 1Department of Cell Biology, Free University, Amsterdam, The Netherlands.

Immunobiology
|September 1, 1991
PubMed

Insights

Distinguishing dendritic cells (DCs) from macrophages (M phi) is challenging. A novel method using the EBM11 marker reveals distinct cellular localization in DCs versus M phi, improving identification.

Area of Science:

  • Immunology
  • Cell Biology

Background:

  • Dendritic cells (DCs) and macrophages (M phi) are antigen-presenting cells often confused due to similar MHC class II expression.
  • Lack of specific markers hinders accurate discrimination between DCs and M phi.

Purpose of the Study:

  • To identify a specific marker for distinguishing human dendritic cells (DCs) from macrophages (M phi).
  • To investigate the cellular localization of the EBM11 (anti-CD68) marker in DCs and M phi.

Main Methods:

  • Immunohistochemistry using the EBM11 (anti-CD68) antibody.
  • Light and electron microscopy.
  • Analysis of cells before and after short-term culture.

Main Results:

  • EBM11 reactivity shows distinct localization: a juxtanuclear spot in DCs versus diffuse cytoplasmic staining in M phi.
  • The EBM11 spot in DCs is observed after short-term culture, a common DC enrichment step.
  • Before culture, DCs and M phi are morphologically and marker-wise indistinguishable.

Conclusions:

  • EBM11 provides a reliable method to differentiate human DCs from M phi.
  • The lysosomal apparatus structure plays a significant role in distinguishing these antigen-presenting cells.
  • Suggests a close relationship between M phi and DCs, with potential functional implications.

Related Concept Videos